We studied serum concentrations of manganese superoxide dismutase (Mn
SOD) and copper-zinc superoxide dismutase (Cu/Zn SOD) in 22 patients w
ith polymyositis and dermatomyositis (PM/DM), 87 patients with four ty
pes of muscular dystrophy, 20 patients with amyotrophic lateral sclero
sis, and 15 patients with collagen vascular diseases (CVD). Serum leve
ls of Mn SOD were increased only in the patients with PM/DM and CVD, a
nd the elevation was more prominent in those with PM/DM. Levels of Cu/
Zn SOD were slightly elevated in some patients with PM/DM and Duchenne
muscular dystrophy. In patients with PM/DM, the change in Mn SOD leve
ls corresponded to disease activity as closely as or more closely than
those of creatine kinase. The results indicate that serum Mn SOD may
be a useful clinical marker for PM/DM.